Next Article in Journal
Nanovaccines against Viral Infectious Diseases
Next Article in Special Issue
Validation of a Dendritic Cell and CD4+ T Cell Restimulation Assay Contributing to the Immunogenicity Risk Evaluation of Biotherapeutics
Previous Article in Journal
A Bioluminescence-Based Ex Vivo Burn Wound Model for Real-Time Assessment of Novel Phage-Inspired Enzybiotics
Previous Article in Special Issue
Pulmonary Safety Profile of Esc Peptides and Esc-Peptide-Loaded Poly(lactide-co-glycolide) Nanoparticles: A Promising Therapeutic Approach for Local Treatment of Lung Infectious Diseases
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(12), 2555; https://doi.org/10.3390/pharmaceutics14122555
Action Date Notes Link
article xml file uploaded 22 November 2022 12:17 CET Original file -
article xml uploaded. 22 November 2022 12:17 CET Update https://www.mdpi.com/1999-4923/14/12/2555/xml
article pdf uploaded. 22 November 2022 12:17 CET Version of Record https://www.mdpi.com/1999-4923/14/12/2555/pdf
article html file updated 22 November 2022 12:18 CET Original file -
article html file updated 1 March 2023 00:15 CET Update -
article html file updated 3 March 2023 21:55 CET Update https://www.mdpi.com/1999-4923/14/12/2555/html
Back to TopTop